Scientia Ventures

knowledge is power

In short

Intelligent Investment in Healthcare

In Numbers

31 Companies Funded

5 IPOs



Latest Press

Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine LAI Program

ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive Results from Study 403 in Mixed Features

VERIGRAFT: Major regulatory safety milestone reached in the TECVI-1 trial


Royalty Pharma

Transforming the funding of life sciences through collaborative capital, Royalty Pharma developed and is the leader in the pharmaceutical royalty business.


ADC Therapeutics

ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates for the treatment of both solid and hematological cancers.


Intra-Cellular Therapies

Intra-Cellular Therapies is a leading biopharmaceutical company founded by Nobel Prize winner: Paul Greengard...